Literature DB >> 26886087

Radio-contrast agent-induced hyperthyroidism: case report and review of the literature.

Ioannis Iakovou1, Apostolos Zapandiotis2, Vassileios Mpalaris1, Dimitrios G Goulis2.   

Abstract

A 66 year-old woman with a history of a euthyroid multinodular goiter underwent a head and neck computed tomography (CT) scan (total iodine load of 35 g) in order to evaluate the extent of retrosternal expansion. Less than 24 h after the iodine-based contrast media (ICM) administration, she presented with symptoms and laboratory findings typical of thyrotoxicosis. She was treated successfully with antithyroid medications. This is the shortest time reported in the literature and it is of clinical importance, as it may have an impact to the recommendations given by the attending physician. Given the fact that a large number of ICM examinations are performed in everyday practice, physicians should be aware of this possible thyroid-specific effect. Prophylactic drugs could be considered in high-risk populations, such as administration of perchlorate and a thionamide class drug to elderly patients with suppressed TSH and/or palpable goiter, started the day before and continued for two weeks after ICM administration.

Entities:  

Year:  2016        PMID: 26886087     DOI: 10.1590/2359-3997000000143

Source DB:  PubMed          Journal:  Arch Endocrinol Metab        ISSN: 2359-3997            Impact factor:   2.309


  3 in total

1.  2021 European Thyroid Association Guidelines for the Management of Iodine-Based Contrast Media-Induced Thyroid Dysfunction.

Authors:  Tomasz Bednarczuk; Thomas H Brix; Wolfgang Schima; Georg Zettinig; George J Kahaly
Journal:  Eur Thyroid J       Date:  2021-06-16

2.  Iodide-induced Hyperthyroidism Within Four Hours of Iodide Load: A Case Report and Review.

Authors:  Noel D Torres Acosta; Suguni Loku Galappaththy; Brandon Barthel
Journal:  Cureus       Date:  2019-10-22

3.  Heart failure as a serious complication of iodinated contrast-induced hyperthyroidism: case-report.

Authors:  Sofie M Diepenbroek; A de Jonghe; C van Rees; E Seebus
Journal:  BMC Endocr Disord       Date:  2021-10-20       Impact factor: 2.763

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.